AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braffman, B.
Right arrow Articles by Zimmerman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braffman, B.
Right arrow Articles by Zimmerman, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 152, Issue 1, 159-165
Copyright © 1989 by American Roentgen Ray Society


Articles

MR imaging of Parkinson disease with spin-echo and gradient-echo sequences

BH Braffman, RI Grossman, HI Goldberg, MB Stern, HI Hurtig, DB Hackney, LT Bilaniuk, and RA Zimmerman

Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104.

High-field MR with both spin-echo and gradient-echo sequences was performed in 21 patients with (idiopathic, drug-responsive) Parkinson disease. The use of gradient echoes allowed more sensitive detection than did spin echoes of susceptibility changes in the putamina and substantia nigra. No statistically significant difference in putaminal hypointensity on long TR/long TE spin-echo sequences or on T2*-weighted images using gradient-echo sequences was observed between Parkinson patients and controls. There was also no statistically significant difference in the frequency of restoration of the signal intensity of the substantia nigra between the two groups of patients. The width of the pars compacta of the substantia nigra in patients with Parkinson disease was 2.12 + 0.82 mm (mean +/- SD). This value in age- and gender-matched controls was 2.67 +/- 0.5. Comparing these two groups with an unpaired t test resulted in a p value less than or equal to .005. Our MR study with spin-echo and gradient-echo images in Parkinson and control patients was able to substantiate and elaborate on previously described MR features of Parkinson disease.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
K. Bhattacharya, D. Saadia, B. Eisenkraft, M. Yahr, W. Olanow, B. Drayer, and H. Kaufmann
Brain Magnetic Resonance Imaging in Multiple-System Atrophy and Parkinson Disease: A Diagnostic Algorithm
Arch Neurol, May 1, 2002; 59(5): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Roentgen Ray Society.